Moreover, based on evidence obtained in MDA-MB-231 breast cancer cells, it was proposed that ERK5 blocks p21 expression via a mechanism that implicates c-MYC-dependent transcriptional regulation of the miR-17-92 cluster [66]. This evidence concerns the gene MAPK7 and breast carcinoma.